MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹541 Cr | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹541 Cr |
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹290 Cr |
| Mar2022 | ₹167 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹541 Cr | 62.64 | |
| Mar2025 | ₹333 Cr | 38.03 | |
| Mar2024 | ₹241 Cr | -16.89 | |
| Mar2023 | ₹290 Cr | 74.27 | |
| Mar2022 | ₹167 Cr | - | |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹477.3 Cr | -3.1% | -8.4% | -8.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,052.6 Cr | 2.6% | -1.2% | -32.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,216.4 Cr | 0.3% | 5.3% | 4.8% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,305.5 Cr | -1.9% | 20.6% | 16.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹953.2 Cr | 1.7% | 9.4% | NA | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹299.0 Cr | 1.3% | -2.8% | -13.2% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -3.1% |
-8.4% |
-8.3% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses